AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05340101 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ROGRESSIVE MUSCLE RELAXATION EXERCISE
Description: In the application, Relaxation Exercises CD Audio Recordings prepared by the Turkish Psychological Association were used. In the the second part of 30 minutes were explained with the sound of the PKGE stream and verbal instructions. Audio recordings in the second part were used in this study. In line with the PCGE sound recordings, each muscle group starting from the hands to the feet, and then the facial and whole body muscles were stretched for about 10 seconds. The exercise was applied by taking deep breaths while tensing each muscle group, and releasing this breath slowly during relaxation. The relaxation lasted 10-20 seconds before the next muscle group was stretched. In this way, the muscles groups in the hands, arms, neck, shoulders, chest, abdomen, hips, feet and fingers, face and whole body were voluntarily stretched and relaxed, respectively, and the students were relaxed.
Study NCT06224972 — intervention group
Intervention type: DEVICE
Intervention: Vlab
Description: The study is observational, there is no intervention.
Study NCT05820009 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GORE® VIABIL® Biliary Endoprosthesis
Description: Endoscopic treatment of benign biliary stricture secondary to Chronic Pancreatitis with the GORE® VIABIL® Biliary Endoprosthesis.
Study NCT05820009 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GORE® VIABIL® Short Wire Biliary Endoprosthesis
Description: Endoscopic treatment of benign biliary stricture secondary to Chronic Pancreatitis with GORE® VIABIL® Short Wire Biliary Endoprosthesis
Study NCT05411328 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: virtual reality
Description: All children in the two groups received physical therapy protocol for 30 minutes in addition to virtual reality game traditional physical therapy group traditional physical therapy group
Study NCT04676542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: One hour of a beginning martial art class ,and a one hour walk at 4.0 mph pace.
Study NCT05724017 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Street Games Intervention
Description: The children to be included in the study will be grouped in groups of 10 according to their age groups. Groups of 10 people consist of six sessions in total, two days a week for three weeks. Applications will be made in the school garden. In the meetings, games that attract the attention of children will be discussed, suitable games will be played, origami, painting and story sharing will be made. In the study, the independent variable street games intervention will be applied.
Study NCT05128526 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise
Description: Short foot exercises without respiratory exercises
Study NCT05128526 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: respiratory
Description: Short foot exercises with respiratory exercises
Study NCT05271903 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MAMA Intervention
Description: The MAMA intervention will be based on PRONTO International's simulation training program to improve obstetric care delivery. The PRONTO curriculum is based on simulation and debrief of clinical scenarios, case-based learning, skills stations, and interactive teamwork and communication activities. Through the training, providers review and learn clinical skills related to obstetric care and emergencies, while reflecting on and practicing principles of respectful maternity care. The simulation exercises give providers and opportunity to act as the patient and develop empathy for the patient experience, and debriefing after simulation includes a reflection and discussion about RMC principles. The training will be two full days, followed by a refresher training in the clinical setting after one month.
Study NCT04625361 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC122505MsOH
Description: Part2：Mulltiple doses once daily, up to 8 days
Study NCT05275296 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intracranial stent for wide-necked aneurysms
Description: Intracranial stent for wide-necked aneurysms
Study NCT04592471 — intervention group
Intervention type: DEVICE
Intervention: kneeMID500-STRONG700
Description: At least 30 patients (15 patients in the orthosis group and 15 patients in the control group) per device type (2 device types: Knee MID 500 and Knee STRONG 700) totalling 60 patients will be included. Patients included in the orthosis group will use the device during sports sessions while patients included in the control group will not use a knee support device.
Study NCT05778695 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone Ester (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
Description: Ketone ester (KE) dietary supplement (KetoneAid)
Study NCT06012630 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultarsound
Description: Median nerve evaluation of participants with ultrasound
Study NCT05637177 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Anging Wisely
Description: The program includes 11 meetings of two hours in a group of up to eight people. The sessions are held weekly. Each lesson is given a homework assignment. A total of 10 groups will take place.
Study NCT05637177 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music therapy
Description: Music therapy sessions are held once a week for 60 minutes for 12 weeks. The maximum number of participants per group is 12. A total of 10 groups will be implemented.
Study NCT05637177 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reminiscence therapy
Description: Reminiscence therapy sessions are held once a week for 60 minutes for 12 weeks. The maximum number of participants per group is 10. A total of 5 groups will be implemented.
Study NCT05637177 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive training
Description: Intervention cognitive training will take place once a week for 45 minutes for 20 weeks. Seniors can choose from two options: 1. group training full-time or home training (online) using the comprehensive training program MENTEM.
Study NCT05637177 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational activities
Description: Interventions in educational activities will run for one academic year. In total, seniors will attend 16 lectures in each educational module. The lectures will run 1 x 14 days for 90 minutes.
Study NCT05360251 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PDL(595nm)
Description: One subject was treated with pulsed dye laser (Vbeam platinum, 595 nm, Candela Corporation): energy dosages of 9-11 J/cm2, pulse durations of 10/20 ms, and spot size of 7 mm.
Study NCT05360251 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IPL(DPL)
Description: One subject was treated with IPL(delicate Pulsed Light, Dye-VL, Alma Lasers Corporation): energy dosages of 8.4-10.6 J/cm2, pulse durations of 10/12 ms, and spot size of 10×30 mm.
Study NCT05360251 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IPL(M22 590)
Description: One subject was treated with IPL(M22 590, 590-1200nm, Lumenis Limited): energy dosages of 15-18 J/cm2, pulse durations of 3-4 ms, pulse delay of 30-40 ms, and spot size of 15×35 mm.
Study NCT05275296 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intracranial stent for wide-necked aneurysms
Description: Intracranial stent for wide-necked aneurysms
Study NCT05360251 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IPL(M22 vascular)
Description: One subject was treated with IPL(M22 vascular, 530-650nm and 900-1200nm, Lumenis Limited): energy dosages of 9-17 J/cm2, pulse durations of 4-6 ms, pulse delay of 20-40 ms, and spot size of 15×35 mm.
Study NCT05304442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric]
Description: Single Dose of IV Iron
Study NCT05304442 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferrous Sulfate 65 mg elemental iron (325 mg tablets)
Description: Once daily by mouth for 42 days
Study NCT03646058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Description: Buprenorphine, 0.4mg pills, sublingual
Study NCT03646058 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo pills, sublingual, specifically made to mimick buprenorphine pills
Study NCT04560140 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Narrative and Skills-building Intervention
Description: The intervention is grounded in Narrative Theory and Bandura's principles of Self-efficacy and Outcome Expectation. It will consist of eight individual sessions over six months delivered by a facilitator. Participants will be facilitated to narrate their survival experiences and rebuild core life skills.
Study NCT04765748 — intervention group
Intervention type: DEVICE
Intervention: Cytosorb
Description: Cytokine filter, which can be used intraoperatively while using a heart lung machine
Study NCT04953065 — intervention group
Intervention type: OTHER
Intervention: COVID-19 vaccine hesitancy and acceptance survey
Description: Participants will be provided with a COVID-19 vaccine hesitancy and acceptance survey developed by the study team.
Study NCT06373276 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: multiplanar balance training exercise with education
Description: 7 minute daily balance training exercises
Study NCT06373276 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: education only
Description: 5 educational broshures
Study NCT04578015 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metronidazole
Description: Participants in this arm will receive metronidazole 500 mg twice daily, orally for 7 days
Study NCT04578015 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants in this arm will receive placebo
Study NCT06524596 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tartaric acid butorphanol
Description: The group received 0.02 mg/kg tartaric acid butorphanol intravenously over 5 minutes, 30 minutes before anaesthesia induction
Study NCT06524596 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: The group received 0.02 mg/kg normal saline intravenously over 5 minutes, 30 minutes before anaesthesia induction
Study NCT06524596 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: propofol and remifentanil
Description: Anaesthesia was induced with 2 mg/kg propofol and 0.6 μg/kg remifentanil and maintained with a target-controlled infusion (TCI) of propofol and remifentanil, using the Marsh and Minto models, respectively.
Study NCT06524596 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: propofol and remifentanil
Description: Anaesthesia was induced with 2 mg/kg propofol and 0.6 μg/kg remifentanil and maintained with a target-controlled infusion (TCI) of propofol and remifentanil, using the Marsh and Minto models, respectively.
Study NCT06003439 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Program
Description: Behavioral: Virtual Reality Program The VR Program will be pre-installed on Meta Quest 2 headsets, which will be donned by students as a class to experience the intervention for approximately the length of one school class period (approximately 30-40 minutes). Each participant will experience the program once a week for 3 weeks. Participants who missed a week will complete the program by the 4th or 5th week.
Study NCT06003439 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VR Program
Description: VR program participants will be able to download a mobile app that complements and reinforces the school-based VR session.
Study NCT06379828 — intervention group
Intervention type: OTHER
Intervention: Please note that this is an observational study; not applicable
Description: Please note that this is an observational study; not applicable
Study NCT06204887 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual dynamic activation
Description: The root canals were filled with irrigation solutions. A main gutta percha cone was positioned 1 mm shorter than the working length and 2 mm coronal-apical direction movement was performed at a rate of 100 strokes per minute during 60 s.
Study NCT06204887 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Passive ultrasonic activation
Description: A non-cutting ultrasonic tip (IRRI S 21/25; VDW, Munich, Germany) coupled to an ultrasonic device (DTE S6 Led, Guilin Woodpecker Co., Guilin, Guangxi, China) (mode: E, setting: 6) was used according to the manufacturer's recommendations.
Study NCT06204887 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laser activation
Description: A 2940 nm Er:YAG-laser device (Lightwalker, Fotona, Ljubljana, Slovenia), equipped with a handpiece (H14, Fotona) holding a 8.5 mm long and 600 µm diameter-tapered fiber tip (SWEEPS 600, Fotona) was used for irrigation activation. The device was set to AutoSWEEPS mode with two ultrashort micropulse durations (25 μs) continuously varying at 0.3 W, 20 mJ, 15 Hz settings. The air and water sprays were turned off.
Study NCT04600921 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ertugliflozin 5 mg
Description: The subject will receive Ertugliflozin 5mg orally once daily for 52 weeks.
Study NCT04600921 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 5mg
Description: The subject will receive Placebo 5mg orally daily for 52 weeks.
Study NCT06487234 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Functional band
Description: Participants will wear the functional band for 1-hour electroacupuncture stimulation
Study NCT06487234 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo band
Description: Participants will wear the nonfunctioning band for 1-hour with no electroacupuncture stimulation
Study NCT05173974 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Super Poligrip Free
Description: A single application of 1 gram of Super Poligrip Free will be applied topically to oral tissues via the upper denture.
Study NCT05173974 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental Denture Adhesive 1
Description: A single application of 1 gram of Experimental Denture Adhesive 1 will be applied topically to oral tissues via the upper denture.
Study NCT05173974 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental Denture Adhesive 2
Description: A single application of 1 gram of Experimental Denture Adhesive 2 will be applied topically to oral tissues via the upper denture.
Study NCT05087498 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: autologous cord blood mononuclear cells
Description: preterm neonates less than 32 weeks are assigned to receive intravenous autologous cord blood mononuclear cells infusion (2-10×107cells/kg) within 24 hours after birth
Study NCT05087498 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: preterm neonates less than 32 weeks are assigned to receive normal saline within 24 hours after birth
Study NCT04860115 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Modified pectoralis block (PEC II) and pecto-intercostal fascial plane block (PIFB)
Description: PECS II: Ultrasound guided block involving injection of 20 ml of 0.25% L-bupivacaine with dexmetomidine into an interfascial plane between the serratus anterior muscle and the external intercostal muscles followed by the needle withdrawal into an interfascial plane between the pectoralis major and pectoralis minor muscle where further 10ml will be administered.~PIFB: Ultrasound guided block involving injection of 10 ml of 0.25% L-bupivacaine with dexmetomidine into an iterfascial plane between the pectoralis major and the intercostal muscles approximately 2 cm laterally from the sternum to cover T2 to T6 dermatomes.
Study NCT04650438 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) over the left inferior frontal gyrus (IFG)
Description: MagPro X100, with MagPro software version 7.1; connected to a figure-of-eight coil (MC-B70) or a circular coil (MC-125). The device is CE marked and bears an ISO 13485 certificate complying with good manufacturing practice. Continuous theta burst stimulation protocol will be applied.
Study NCT05656495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate intramuscularly
Description: lyophilizate for preparation of solution for intramuscular administration 1 mg 1 time per day for 10 days
Study NCT05656495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate inhaled
Description: lyophilizate for preparation of solution for inhalation administration 10 mg 1 time per day for 10 days
Study NCT05656495 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: The administration of 'StandardTherapy' drugs was done according to the regimen recommended in the 'COVID-19TreatmentGuidelines'(current version)
Study NCT05315544 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CSI pVAD system
Description: The CSI percutaneous ventricular assist device (pVAD) is being investigated as a temporary left ventricular system intended to support and/or provide hemodynamic stability during high-risk percutaneous coronary interventions.
Study NCT05004103 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cosmetic products application
Description: Female healthy volunteers applied cosmetic products (cleanser and moisturizer) in the morning and afternoon for 1 month. Seven days wash out period will be conducted prior study starts. The evaluation will be conducted before, two weeks after treatment starts, and at the end of the study.
Study NCT05279339 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Upper limb exercises using an elastic band.
Study NCT05022082 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chest Physiotherapy- Aspiration- Inhaler drugs group
Description: In the intensive care unit where the study was conducted, the patients who have a respiratory disorder and receive supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask are first administered an inhaler drug therapy placed in the physician's order. It is followed by chest physiotherapy and then oropharyngeal and nasopharyngeal aspiration. However, in practice rendered by the researcher, it is suggested that when chest physiotherapy and aspiration are administered in the first place and then followed by an inhaler drug therapy, it might have a more positive impact on the patient's physiologic parameters.
Study NCT05022082 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Chest Physiotherapy- Aspiration- Inhaler drugs group
Description: In the intensive care unit where the study was conducted, the patients who have a respiratory disorder and receive supplemental oxygen therapy with non-invasive mechanical ventilation or an oxygen mask are first administered an inhaler drug therapy placed in the physician's order. It is followed by chest physiotherapy and then oropharyngeal and nasopharyngeal aspiration. However, in practice rendered by the researcher, it is suggested that when chest physiotherapy and aspiration are administered in the first place and then followed by an inhaler drug therapy, it might have a more positive impact on the patient's physiologic parameters.
Study NCT04650438 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) over the left inferior parietal lobule (IPL)
Description: MagPro X100, with MagPro software version 7.1; connected to a figure-of-eight coil (MC-B70) or a circular coil (MC-125). The device is CE marked and bears an ISO 13485 certificate complying with good manufacturing practice. Continuous theta burst stimulation protocol will be applied.
Study NCT06167967 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ctDNA methylation
Description: A blood-based circulating tumor DNA methylation assay that uses 6 different methylation markers, SEPT9 region1, SEPT9 region2, BCAT1, IKZF1, BCAN and VAV3.
Study NCT06167967 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: standard treatment
Description: This group was treated according to standard procedure
Study NCT05531006 — intervention group
Intervention type: OTHER
Intervention: retrospective cohort study
Description: retrospective patient file review
Study NCT05689879 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: STOP arm
Description: TNF-alpha antagonists withdrawal
Study NCT05466734 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cilostazol Tablet 100 mg
Description: Two oral doses (total daily dose of 200 mg)
Study NCT05466734 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: PMR Tablet 135 mg
Description: Single oral dose (total daily dose of 270 mg)
Study NCT05843071 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal sprays with sea salts
Description: Nasal sprays for nasal congestion and dryness